- Novo Nordisk Inc. (Plainsboro, NJ)
- …and assets. The Rare Disease portfolio includes products in the hemophilia and growth disorders therapeutic areas, new products in the pipeline, and products ... acquired through business development efforts in existing and new areas. The STARS team collaborates and partners with...on shaping our future. The Position The Hemophilia TA Lead is instrumental in shaping and executing NNI's strategic… more
- Merck & Co. (Rahway, NJ)
- Job DescriptionThe Global Brand Lead , Neuroscience is responsible for driving the creation and execution of the early commercial strategy for our company's emerging ... forecasts for in-flight and emerging discovery programs.The Director, Global Brand Lead is focused on developing a future-focused view of company's Neuroscience… more
- Formation Bio (New York, NY)
- …trials. Recognizing that this development bottleneck may ultimately limit the number of new medicines that can reach patients, Formation Bio, founded in 2016 as ... proof of concept and beyond, ultimately helping to bring new medicines to patients. The company is backed by...Capital, Sam Altman, John Doerr, Spark Capital, SV Angel Growth , and others. You can read more at the… more
- Formation Bio (New York, NY)
- …trials. Recognizing that this development bottleneck may ultimately limit the number of new medicines that can reach patients, Formation Bio, founded in 2016 as ... proof of concept and beyond, ultimately helping to bring new medicines to patients. The company is backed by...Capital, Sam Altman, John Doerr, Spark Capital, SV Angel Growth , and others. You can read more at the… more
- Formation Bio (New York, NY)
- …trials. Recognizing that this development bottleneck may ultimately limit the number of new medicines that can reach patients, Formation Bio, founded in 2016 as ... proof of concept and beyond, ultimately helping to bring new medicines to patients. The company is backed by...Capital, Sam Altman, John Doerr, Spark Capital, SV Angel Growth , and others. You can read more at the… more
- Formation Bio (New York, NY)
- …trials. Recognizing that this development bottleneck may ultimately limit the number of new medicines that can reach patients, Formation Bio, founded in 2016 as ... proof of concept and beyond, ultimately helping to bring new medicines to patients. The company is backed by...Capital, Sam Altman, John Doerr, Spark Capital, SV Angel Growth , and others. You can read more at the… more
- Formation Bio (New York, NY)
- …trials. Recognizing that this development bottleneck may ultimately limit the number of new medicines that can reach patients, Formation Bio, founded in 2016 as ... proof of concept and beyond, ultimately helping to bring new medicines to patients. The company is backed by...Capital, Sam Altman, John Doerr, Spark Capital, SV Angel Growth , and others. You can read more at the… more
- Formation Bio (New York, NY)
- …trials. Recognizing that this development bottleneck may ultimately limit the number of new medicines that can reach patients, Formation Bio, founded in 2016 as ... proof of concept and beyond, ultimately helping to bring new medicines to patients. The company is backed by...Capital, Sam Altman, John Doerr, Spark Capital, SV Angel Growth , and others. You can read more at the… more
- Formation Bio (New York, NY)
- …trials. Recognizing that this development bottleneck may ultimately limit the number of new medicines that can reach patients, Formation Bio, founded in 2016 as ... proof of concept and beyond, ultimately helping to bring new medicines to patients. The company is backed by...Capital, Sam Altman, John Doerr, Spark Capital, SV Angel Growth , and others. You can read more at the… more
- Merck & Co. (Rahway, NJ)
- …to achieve optimal results with limited day-to-day direction from Therapeutic Area Lead .Strong verbal and written communication skills Preferred Experience: ... (Principal Scientist), Global Regulatory Affairs Liaison with a visionary, growth -oriented mindset that can help advance our pipeline and...where the compound is first-in-class or is in a new therapeutic area for our company; where… more
- Formation Bio (New York, NY)
- …and more efficiently.About the PositionWe are seeking a seasoned Staff Engineer to lead our AI Foundations Team-a new initiative dedicated to establishing the ... this development bottleneck may ultimately limit the number of new medicines that can reach patients, Formation Bio, founded...Capital, Sam Altman, John Doerr, Spark Capital, SV Angel Growth , and others. You can read more at the… more
- Formation Bio (New York, NY)
- …bring new treatments to patients faster and more efficiently.Responsibilities Lead the design, development, and deployment of software solutions that leverage AI ... this development bottleneck may ultimately limit the number of new medicines that can reach patients, Formation Bio, founded...Capital, Sam Altman, John Doerr, Spark Capital, SV Angel Growth , and others. You can read more at the… more
- Novo Nordisk Inc. (Plainsboro, NJ)
- …the FDA to providing medical education and collecting data to support efficacy and new product development, CMR is involved. The one thing that keeps us all marching ... lives for a living. Are you ready to make a difference? The Position Lead the Medical Promotional Review staff and direct their activities, across all therapeutic… more
- Formation Bio (New York, NY)
- …trials. Recognizing that this development bottleneck may ultimately limit the number of new medicines that can reach patients, Formation Bio, founded in 2016 as ... proof of concept and beyond, ultimately helping to bring new medicines to patients. The company is backed by...Capital, Sam Altman, John Doerr, Spark Capital, SV Angel Growth , and others. You can read more at the… more
- Formation Bio (New York, NY)
- …trials. Recognizing that this development bottleneck may ultimately limit the number of new medicines that can reach patients, Formation Bio, founded in 2016 as ... proof of concept and beyond, ultimately helping to bring new medicines to patients. The company is backed by...Capital, Sam Altman, John Doerr, Spark Capital, SV Angel Growth , and others. You can read more at the… more
- Formation Bio (New York, NY)
- …trials. Recognizing that this development bottleneck may ultimately limit the number of new medicines that can reach patients, Formation Bio, founded in 2016 as ... proof of concept and beyond, ultimately helping to bring new medicines to patients. The company is backed by...Capital, Sam Altman, John Doerr, Spark Capital, SV Angel Growth , and others. You can read more at the… more
- Formation Bio (New York, NY)
- …trials. Recognizing that this development bottleneck may ultimately limit the number of new medicines that can reach patients, Formation Bio, founded in 2016 as ... proof of concept and beyond, ultimately helping to bring new medicines to patients. The company is backed by...Capital, Sam Altman, John Doerr, Spark Capital, SV Angel Growth , and others. You can read more at the… more
- Lundbeck (New York, NY)
- …advance brain health and transform lives. Join us on our journey of growth !BioPharmaceutical Regional Business Director - East Will consider candidates who live in ... KY.SUMMARY:The Regional Business Director (RBD) is responsible for leading field-based Area Sales Managers (ASM) and Biopharmaceutical Account Managers (BAM) to… more
- Merck & Co. (Rahway, NJ)
- …strategic initiatives across our company as well as the establishment of new strategies, and capabilities. This role will work cross-functionally with senior leaders ... Associate Vice President, Head of Commercial Strategy Development.Located in Rahway, New Jersey preferred, candidates from Upper Gwynedd, Pennsylvania, will be… more
- Daiichi Sankyo, Inc. (Bernards, NJ)
- …United States (such as Global Marketing, Global Medical Affairs). For these areas, acts as lead attorney for that area providing legal advice and support for the ... legacy of innovation and a robust pipeline of promising new medicines to help people. Under the Group's 2025...as a mentor in order to foster their professional growth and development as well as their achievement of… more
